Mathias Vormehr

12.1k total citations · 2 hit papers
23 papers, 1.8k citations indexed

About

Mathias Vormehr is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Mathias Vormehr has authored 23 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 17 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Mathias Vormehr's work include Immunotherapy and Immune Responses (20 papers), Cancer Immunotherapy and Biomarkers (12 papers) and CAR-T cell therapy research (11 papers). Mathias Vormehr is often cited by papers focused on Immunotherapy and Immune Responses (20 papers), Cancer Immunotherapy and Biomarkers (12 papers) and CAR-T cell therapy research (11 papers). Mathias Vormehr collaborates with scholars based in Germany, United States and Netherlands. Mathias Vormehr's co-authors include Uğur Şahin, Özlem Türeci, Mustafa Diken, Sebastian Kreiter, Sebastian Boegel, Barbara Schrörs, Christoph Huber, Martin Löwer, Arbel D. Tadmor and Fulvia Vascotto and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Mathias Vormehr

23 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mutant MHC class II epitopes drive therapeutic immune responses to cancer

2015 915 citations Sebastian Kreiter, Mathias Vormehr et al. Nature profile →
mRNA therapeutics in cancer immunotherapy

2021 272 citations Jan D. Beck, Nadja Salomon et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mathias Vormehr Germany	13	1.2k	990	850	166	153	23	1.8k
Barbara Schrörs Germany	12	1.2k 1.0×	1.0k 1.0×	783 0.9×	102 0.6×	163 1.1×	23	1.7k
Jan Diekmann Germany	10	1.4k 1.1×	1.1k 1.1×	717 0.8×	131 0.8×	92 0.6×	12	1.8k
Sander Kelderman Netherlands	10	1.2k 1.0×	1.4k 1.4×	526 0.6×	169 1.0×	295 1.9×	12	2.0k
Carsten Linnemann Netherlands	17	1.8k 1.4×	1.7k 1.7×	736 0.9×	316 1.9×	130 0.8×	21	2.5k
Sara Bobisse Switzerland	19	667 0.5×	1000 1.0×	1.1k 1.3×	164 1.0×	83 0.5×	31	1.8k
Niels van de Roemer Germany	3	1.3k 1.0×	1.0k 1.1×	597 0.7×	103 0.6×	90 0.6×	7	1.5k
Cleo Goyvaerts Belgium	23	821 0.7×	648 0.7×	646 0.8×	175 1.1×	86 0.6×	48	1.4k
Marit M. van Buuren Netherlands	12	1.7k 1.3×	1.7k 1.7×	680 0.8×	104 0.6×	77 0.5×	17	2.2k
Raquel Gomez-Eerland Netherlands	10	907 0.7×	913 0.9×	426 0.5×	142 0.9×	82 0.5×	14	1.4k
Cristina Puig-Saus United States	13	1.0k 0.8×	1.4k 1.4×	704 0.8×	238 1.4×	161 1.1×	18	2.0k

Countries citing papers authored by Mathias Vormehr

Since Specialization

Citations

This map shows the geographic impact of Mathias Vormehr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathias Vormehr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathias Vormehr more than expected).

Fields of papers citing papers by Mathias Vormehr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathias Vormehr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathias Vormehr. The network helps show where Mathias Vormehr may publish in the future.

Co-authorship network of co-authors of Mathias Vormehr

This figure shows the co-authorship network connecting the top 25 collaborators of Mathias Vormehr. A scholar is included among the top collaborators of Mathias Vormehr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathias Vormehr. Mathias Vormehr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kranz, Lena M., David Eisel, Mustafa Diken, et al.. (2024). RNA-encoded Interleukin 2 with Extended Bioavailability Amplifies RNA Vaccine–Induced Antitumor T-cell Immunity. Cancer Immunology Research. 12(10). 1409–1420. 3 indexed citations

Beck, Jan D., Mustafa Diken, M Suchan, et al.. (2024). Long-lasting mRNA-encoded interleukin-2 restores CD8+ T cell neoantigen immunity in MHC class I-deficient cancers. Cancer Cell. 42(4). 568–582.e11. 34 indexed citations

Schrörs, Barbara, Martin Löwer, Franziska Lang, et al.. (2023). MC38 colorectal tumor cell lines from two different sources display substantial differences in transcriptome, mutanome and neoantigen expression. Frontiers in Immunology. 14. 1102282–1102282. 9 indexed citations

Beck, Jan D., Nadja Salomon, Uğur Şahin, et al.. (2021). mRNA therapeutics in cancer immunotherapy. Molecular Cancer. 20(1). 69–69. 272 indexed citations breakdown →

Vormehr, Mathias, Sophie M. Lehar, Lena M. Kranz, et al.. (2020). Dexamethasone premedication suppresses vaccine-induced immune responses against cancer. OncoImmunology. 9(1). 1758004–1758004. 17 indexed citations

Heinrich, Bernd, Zachary J. Brown, Laurence P. Diggs, et al.. (2020). Steatohepatitis Impairs T-cell–Directed Immunotherapies Against Liver Tumors in Mice. Gastroenterology. 160(1). 331–345.e6. 55 indexed citations

Schrörs, Barbara, Sebastian Boegel, Christian Albrecht, et al.. (2020). Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor Model. Frontiers in Oncology. 10. 1195–1195. 141 indexed citations

Eisel, David, Mathias Vormehr, Karin Müller‐Decker, et al.. (2019). A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice. BMC Cancer. 19(1). 914–914. 1 indexed citations

Vormehr, Mathias, Mustafa Diken, Özlem Türeci, Uğur Şahin, & Sebastian Kreiter. (2019). Personalized Neo-Epitope Vaccines for Cancer Treatment. Recent results in cancer research. 214. 153–167. 7 indexed citations

10.

Vascotto, Fulvia, Jutta Petschenka, Kerstin C. Walzer, et al.. (2019). Intravenous delivery of the toll-like receptor 7 agonist SC1 confers tumor control by inducing a CD8+ T cell response. OncoImmunology. 8(7). e1601480–e1601480. 21 indexed citations

11.

Vormehr, Mathias, Özlem Türeci, & Uğur Şahin. (2019). Harnessing Tumor Mutations for Truly Individualized Cancer Vaccines. Annual Review of Medicine. 70(1). 395–407. 76 indexed citations

12.

Heinrich, Bernd, Zachary J. Brown, Mathias Vormehr, et al.. (2018). Abstract 1728: Nonalcoholic steatohepatitis (NASH) impairs treatment of intrahepatic metastases with CD4+ T cell dependent RNA vaccine. Cancer Research. 78(13_Supplement). 1728–1728. 4 indexed citations

13.

Vormehr, Mathias, Katharina Reinhard, Jan D. Beck, et al.. (2018). A non-functional neoepitope specific CD8⁺ T-cell response induced by tumor derived antigen exposure in vivo. OncoImmunology. 8(3). 1553478–1553478. 13 indexed citations

14.

Diken, Mustafa, Mathias Vormehr, Christian Grunwitz, et al.. (2016). Discovery and Subtyping of Neo-Epitope Specific T-Cell Responses for Cancer Immunotherapy: Addressing the Mutanome. Methods in molecular biology. 1499. 223–236. 9 indexed citations

15.

Türeci, Özlem, Mathias Vormehr, Mustafa Diken, et al.. (2016). Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines. Clinical Cancer Research. 22(8). 1885–1896. 109 indexed citations

16.

Kloke, Björn‐Philipp, Sebastian Kreiter, Mathias Vormehr, et al.. (2016). Actively personalized cancer vaccines--the step into clinical application.. PubMed. 71(1). 43–7. 3 indexed citations

17.

Vormehr, Mathias, Sebastian Kreiter, Niels van de Roemer, et al.. (2016). Abstract A110: Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Cancer Immunology Research. 4(1_Supplement). A110–A110. 1 indexed citations

18.

Vormehr, Mathias, et al.. (2015). Mutanome directed cancer immunotherapy. Current Opinion in Immunology. 39. 14–22. 48 indexed citations

19.

Kreiter, Sebastian, Mathias Vormehr, Niels van de Roemer, et al.. (2015). Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature. 520(7549). 692–696. 915 indexed citations breakdown →

20.

Kranz, Lena M., Matthias Birtel, Christian Grunwitz, et al.. (2015). CIMT 2015: The right patient for the right therapy - Report on the 13th annual meeting of the Association for Cancer Immunotherapy. Human Vaccines & Immunotherapeutics. 12(1). 213–221. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact